Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador

Carcinogenesis

Volumn 17, Issue 5, 1996, Pages 1107-1109

  Kuttan, Girija ^a   Menon, Lata G ^a   Kuttan, Ramadasan ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; VISCUM ALBUM;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; METHYLCHOLANTHRENE; MICE; PLANT EXTRACTS; PLANT PROTEINS; SARCOMA, EXPERIMENTAL;

EID: 0029942120     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.5.1107     Document Type: Article

References (19)

1. DiGiovanni,J. (1992) Multistage carcinogenesis in mouse skin. Pharmcol. Ther., 54, 63-128.
2. Agarwal,R. and Mukhtar,H. (1991) Cutaneous chemical carcinogenesis. In Mukhtar,H. (ed.). Pharmacology of the Skin. CRC Press, Boca Raton, FL, pp. 371-387.
3. Grandis,J.R. and Tweardy,D.J. (1993) Elevated levels of TGF-α and EGF-receptor mRNA are early markers of carcinogenesis in head and neck cancer. Cancer Res., 53, 3579-3584.
4. Evans,M.R. and Preece,A.W. (1973) Viscum album, a possible treatment for cancer? Bristol Med. Chir. J., 88, 17-20.
5. Leroi,R. (1975) Clinical Experience with Mistletoe Preparation, Iscador. Vittorio Klostermann Press, Frankfurt, Germany.
6. Khwaja,T.A., Cecilia,B.D. and Pentecost,S. (1986) Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids. Oncology, 43, 42-50.
7. Kuttan,G., Vasudevan,D.M. and Kuttan,R. (1990) Effect of a preparation of Viscum album on tumour development in vitro and in mice. J. Ethnopharmacol., 29, 35-41.
8. Kuttan,G., Vasudevan,D.M. and Kuttan,R. (1988) Isolation and identification of a tumour reducing component from mistletoe extract (Iscador). Cancer Lett., 41, 307-314.
9. Hajto,T., Hostanska,K. and Gabius,H.J. (1989) Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res., 49, 4803-4808.
10. Jung,M.L., Baudino,S., Gayon,G.R. and Beck,J.P. (1990) Characterisation of cytotoxic proteins from mistletoe (Viscum album L.). Cancer Lett., 51, 103-108.
11. Kuttan,G. and Kuttan,R. (1992) Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635089). Immunol. Invest., 21, 285-296.
12. Rentae,R., Lion,E and Hunter,R. (1981) Biologic properties of Iscador: a Viscum album preparation. Lab. Invest., 44, 41-48.
13. Chang,A.E., Rosenberg,S.A., Glatstein,E.J. and Antman,K.H. (1989) In Devita,V.T.Jr, Hellmann,S. and Rosenberg,S.A. (eds). Cancer: Principles and Practice of Oncology. J.B.Lippincott Co., Philadelphia, PA. Vol. 2, pp. 1345-1398.
14. Salzer,G. and Havelec,L. (1978) Prophylactic treatment against recurrences in cases of operated carcinoma of the bronchial tree with the mistletoe preparation. Oncology, 1, 264-266.
15. Neinhans,J. and Leroi,R. (1970) Tumour inhibition and thymus stimulation with mistletoe preparation. Elemente Naturwissenschaft, 13, 45-54.
16. Hajto,T. (1986) Immunomodulatory effects of Iscador: a Viscum album preparation. Oncology, 43, 51-65.
17. Mannel,D.N., Becker,H. and Gundt,A. (1991) Induction of tumour necrosis factor expression by a lectin from Viscum album. Cancer Immunol. Immunother., 33, 177-182.
18. Kuttan,G. and Kuttan,R. (1992) Immunological mechanism of action of the tumour reducing peptide from mistletoe extract (NSC 635 089)-cellular proliferation. Cancer Lett., 66, 128-130.
19. Kuttan,G., Vasudevan,D.M. and Kuttan,R. (1989) Presence of a receptor for the active component of Iscador in ascites fluid of tumour bearing mice. Cancer Lett.. 48, 223-227.